IIL to invest Rs 75 cr for viral antigen manufacturing facility in Telangana
The company also plans to utilise the facility to manufacture COVID-19 vaccines post completion of its R&D with Griffith…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.